Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parecoxib Versus Morphine in Acute Pain Management for Sickle Cell Disease Patients in Emergency Department: a Randomized Controlled Trial.

NCT06315920 is registered in ClinicalTrials.gov with Oman Medical Speciality Board as lead sponsor.

NCT NCT06315920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06315920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parecoxib Versus Morphine in Acute Pain Management for Sickle Cell Disease Patients in Emergency Department: a Randomized Controlled Trial.
Lead sponsor
Oman Medical Speciality Board
Phase
Phase 3
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
July 1, 2028
Enrollment
226 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sickle-cell disease with crisis